Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors

Clinical trial NCT04960943 · UNKNOWN

Trial details

NCT number: NCT04960943
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Tumor Effect of Drug

Start date: 2020-02-01
Primary completion: 2022-09-09
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.